MedPath

Red Light Ptosis Proof-of-Concept

Not Applicable
Recruiting
Conditions
Mitochondrial Diseases
Blepharoptosis
Registration Number
NCT06292182
Lead Sponsor
University College, London
Brief Summary

This study tests a new treatment to help with droopy eyelids (ptosis) and eye movement problems (squint) in children and young people with genetically confirmed mitochondrial conditions - using red-light.

We use a torch to shine a red light through the closed eyelid for 3 minutes a day. The study will run for 18 months.

We believe that this treatment could help strengthen the muscle in the eyelid to make it easier to open the eyes, and could also help some children with squint.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Primary Outcome Measures
NameTimeMethod
Palpebral fissure width3 months from baseline
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Moorfields Eye Hospital NHS Foundation Trust

🇬🇧

London, United Kingdom

Moorfields Eye Hospital NHS Foundation Trust
🇬🇧London, United Kingdom
Annegret H Dahlmann-Noor, PhD
Contact
020 7253 3411
annegret.dahlmann-noor@nhs.net

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.